WO2008010043A3 - Improved process for the preparation of ceforanide in pure form - Google Patents

Improved process for the preparation of ceforanide in pure form Download PDF

Info

Publication number
WO2008010043A3
WO2008010043A3 PCT/IB2007/001920 IB2007001920W WO2008010043A3 WO 2008010043 A3 WO2008010043 A3 WO 2008010043A3 IB 2007001920 W IB2007001920 W IB 2007001920W WO 2008010043 A3 WO2008010043 A3 WO 2008010043A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pure form
improved process
ceforanide
compound
Prior art date
Application number
PCT/IB2007/001920
Other languages
French (fr)
Other versions
WO2008010043A2 (en
Inventor
Palanisamy Senth Udayampalayam
Sivakumaran Sundaravadivelan
Athmaram Ramesh Konda
Mohamed Anish Raja Raja
Prabhat Kumar Sahoo
Original Assignee
Orchid Chemicals & Pharm Ltd
Palanisamy Senth Udayampalayam
Sivakumaran Sundaravadivelan
Athmaram Ramesh Konda
Mohamed Anish Raja Raja
Prabhat Kumar Sahoo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals & Pharm Ltd, Palanisamy Senth Udayampalayam, Sivakumaran Sundaravadivelan, Athmaram Ramesh Konda, Mohamed Anish Raja Raja, Prabhat Kumar Sahoo filed Critical Orchid Chemicals & Pharm Ltd
Publication of WO2008010043A2 publication Critical patent/WO2008010043A2/en
Publication of WO2008010043A3 publication Critical patent/WO2008010043A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Abstract

The present invention provides an improved process for the preparation of the compound of formula (I) in pure form.
PCT/IB2007/001920 2006-07-18 2007-07-10 Improved process for the preparation of ceforanide in pure form WO2008010043A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1245CH2006 2006-07-18
IN1245/CHE/2006 2006-07-18
IN908CH2007 2007-04-27
IN908/CHE/2007 2007-04-27

Publications (2)

Publication Number Publication Date
WO2008010043A2 WO2008010043A2 (en) 2008-01-24
WO2008010043A3 true WO2008010043A3 (en) 2008-04-03

Family

ID=38957141

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001920 WO2008010043A2 (en) 2006-07-18 2007-07-10 Improved process for the preparation of ceforanide in pure form

Country Status (1)

Country Link
WO (1) WO2008010043A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101926804A (en) * 2010-08-24 2010-12-29 中国医药集团总公司四川抗菌素工业研究所 Ceforanide C-type crystal composition for injection and preparation method thereof
CN102898442A (en) * 2012-10-25 2013-01-30 河南中帅医药科技发展有限公司 Refinement method of ceforanide
CN107805225B (en) * 2017-12-07 2020-06-26 九江中星医药化工有限公司 Preparation method of 5-mercapto tetrazole acetic acid and sodium salt thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100346A (en) * 1975-06-27 1978-07-11 Bristol-Myers Company Certain 7(o-amino-methyl- or methylaminomethylphenyl- or cyclohexadienyl- or thienylacetamide)-3[1-carboxymethyl-(or ethyl- or propyl-)-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
US4118563A (en) * 1977-11-25 1978-10-03 Bristol-Myers Company Production of 7-(2-aminomethylphenylacetamido-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100346A (en) * 1975-06-27 1978-07-11 Bristol-Myers Company Certain 7(o-amino-methyl- or methylaminomethylphenyl- or cyclohexadienyl- or thienylacetamide)-3[1-carboxymethyl-(or ethyl- or propyl-)-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
US4118563A (en) * 1977-11-25 1978-10-03 Bristol-Myers Company Production of 7-(2-aminomethylphenylacetamido-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GOTTSTEIN W.J. ET AL.: "7-(2-aminomethylphenylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid", J ANTIBIOT (TOKYO), vol. 29, no. 11, November 1976 (1976-11-01), pages 1226 - 1229 *

Also Published As

Publication number Publication date
WO2008010043A2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
WO2008083248A3 (en) Cyclopamine analogs
WO2010063700A8 (en) Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides
WO2008005877A3 (en) Inhibitors of c-kit and uses thereof
WO2009156462A3 (en) Organic compounds
WO2007085895A3 (en) Fap inhibitors
WO2008013838A3 (en) Pyridizinone derivatives
WO2008001101A3 (en) Pharmaceutical combinations
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
WO2006122216A3 (en) Processes for production of phenolic 4-biphenylylazetidin-2-ones
WO2008155615A3 (en) An improved process for the preparation of cephalosporin antibiotic
WO2008151828A3 (en) Novel microbiocides
WO2009127718A3 (en) Novel microbiocides
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
WO2008075205A3 (en) Improved process for the preparation of voriconazole
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
WO2009003672A3 (en) Novel microbiocides
WO2009000533A8 (en) Novel herbicides
WO2006127368A3 (en) Methods for synthesizing imidazotriazinones
WO2007087026A3 (en) Solid-state form of amg 706 and pharmaceutical compositions thereof
WO2009140101A3 (en) Imidazopyridine compounds useful as mmp-13 inhibitors
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2010056585A3 (en) Heteroaryl diamide compounds useful as mmp-13 inhibitors
WO2006076350A3 (en) Processes for the preparation of aminoethoxybenzyl alcohols

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07804580

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07804580

Country of ref document: EP

Kind code of ref document: A2